Author: Lenka Hajnovicova
Regulatory report: Japan
Written by Lenka Hajnovicova || 17th September 2020 || Regulatory reports |
This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws ...
Multiple proposals could spell legalisation of hemp and CBD in Israel
Written by Lenka Hajnovicova || 4th September 2020 || Regulatory briefing |
Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products ...
Regulatory report: Uruguay
Written by Lenka Hajnovicova || 15th July 2020 || Regulatory reports |
This report offers a comprehensive overview of the regulatory regime for CBD and cannabis in Uruguay, including rules around extracts, finished products, import/export and medicinal and recreation cannabis ...
Social media and the advertising of CBD: policy report
Written by Lenka Hajnovicova || 2nd July 2020 || Regulatory reports |
This report investigates the current situation with respect to advertising CBD products via the most widely used social media platforms ...
Regulatory report: Czech Republic
Written by Lenka Hajnovicova || 14th May 2020 || Regulatory reports |
This report offers a thorough overview of the current regulatory regime for CBD in the Czech Republic, covering all aspects from extracts and finished products to medical and recreational cannabis ...
Regulatory report: Colombia
Written by Lenka Hajnovicova || 24th April 2020 || Regulatory reports |
Cultivation of cannabis and manufacture of cannabis-derived products is permitted in Colombia under a licence. This report provides all current regulatory information in place in the country ...
Regulatory report: Mexico
Written by Lenka Hajnovicova || 23rd April 2020 || Regulatory reports |
Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation ...
CBD considered a medicine: Finland regulatory report
Written by Lenka Hajnovicova || 9th December 2019 || Regulatory reports |
CBD is considered a medicine in Finland and any CBD-infused product, whether for human or animal use, would be classified as a medicinal product. This report provides a comprehensive overview of the regulatory landscape of CBD in Finland...
Zero THC and no flower in end products: France regulatory report
Written by Lenka Hajnovicova || 20th November 2019 || Regulatory reports |
Cannabis regulation in France is considered to be among the most stringent in Europe and violations of law are punished with severe penalties. This report provides regulatory information on aspects from import and export to finished products and...
CBD flowers, cosmetics and vapes legal, while edibles in grey area: Switzerland regulatory report
Written by Lenka Hajnovicova || 6th November 2019 || Regulatory reports |
CBD is not a scheduled substance in Switzerland, and its legality in the finished product depends on the intended use. This inevitably leads to a somewhat confusing regulatory framework with many different rules and restrictions ...
Slovakia’s parliament dashes hopes that CBD was to be legalised
Written by Lenka Hajnovicova || 28th October 2019 || Regulatory briefing |
CBD remains banned in Slovakia after the country’s parliament, the National Council, defied widespread expectation that the substance would be legalised in line with the rest of Europe ...
CBD oil ‘banned’ but tolerated: Netherlands regulatory report
Written by Lenka Hajnovicova || 1st October 2019 || Regulatory reports |
This report takes a look at the current regulations around CBD in the Netherlands, including information relating to cultivation, processing, extracts, edibles, cosmetics and more ...
Slovakia regulatory snapshot, August 2019
Written by Lenka Hajnovicova || 21st August 2019 || Regulatory reports |
Under Slovak law, CBD is classed as a psychotropic substance and as such it cannot be extracted, stored, or used for manufacture of final products without authorisation under the Narcotics Act ...
Japan regulatory snapshot, August 2019
Written by Lenka Hajnovicova || 5th August 2019 || Regulatory reports |
Japanese law is easygoing on some aspects of the CBD market and very strict on others, as a result of the country’s rigorous regulation of cannabis ...
Germany regulatory report: confusion about CBD status for end users
Written by Lenka Hajnovicova || 12th June 2019 || Regulatory reports |
In this latest look at regulations in Germany, CBD-Intel details how German law and EU rules are governing the CBD market across the country ...
North Carolina regulatory snapshot
Written by Lenka Hajnovicova || 20th May 2019 || Regulatory reports |
As part of our ongoing series of concise reports on how CBD is regulated across the United States, we look at North Carolina – where changes could be on the horizon ...
Michigan regulatory snapshot
Written by Lenka Hajnovicova || 15th May 2019 || Regulatory reports |
CBD products derived from industrial hemp are legal in the US state of Michigan, subject to certain conditions and regulations, which are explained in this CBD-Intel snapshot ...
Turkey regulatory snapshot
Written by Lenka Hajnovicova || 7th May 2019 || Regulatory reports |
While the regulations governing CBD are extremely harsh, the Turkish government recently announced the launch of hemp cultivation for industrial use on a large scale ...
CBD still in grey area but optimism for future: Israel regulatory report
Written by Lenka Hajnovicova || 15th March 2019 || Regulatory reports |
Our latest regulatory report on CBD in Israel covers the hemp plant's status, the import and export of finished product and much more. Cannabis is a dangerous drug under Israeli criminal law; the possibility of legalising industrial hemp is...